Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes

Acta Psychiatrica Scandinavica

Volumn 129, Issue 1, 2014, Pages 54-62

  Alemany, S ^a,b   Arias, B ^a,b   Fatjo Vilas M ^a   Villa, H ^c   Moya, J ^c   Ibanez M I ^c   Ortet, G ^c   Gasto C ^b,d   Fananas L ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT JAUME I   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Cannabis; Genetics; Psychoses; Trauma

Indexed keywords

CANNABIS; CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ALLELE; ARTICLE; CHILD ABUSE; DRUG ABUSE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; PSYCHOSIS;

CANNABIS; GENETICS; PSYCHOSES; TRAUMA;

ADOLESCENT; ADULT; ADULT SURVIVORS OF CHILD ABUSE; ALLELES; CANNABIS; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINEAR MODELS; MALE; MARIJUANA SMOKING; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOSES, SUBSTANCE-INDUCED; YOUNG ADULT;

EID: 84890242585     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12108     Document Type: Article

References (60)

1. Alemany S, Arias B, Aguilera M et al. Childhood abuse, the BDNF-Val66Met polymorphism and adult psychotic-like experiences. Br J Psychiatry 2011;199:38-42.
2. Kelleher I, Connor D, Clarke MC, Devlin N, Harley M, Cannon M. Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies. Psychol Med 2012;9:1-7.
3. Van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 2009;39:179-95.
4. Johns LC, Van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev 2001;21:1125-41.
5. Henquet C, Murray R, Linszen D, Van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005;31:608-12.
6. Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychol Med 2012;42:1321-8.
7. Skinner R, Conlon L, Gibbons D, Mcdonald C. Cannabis use and non-clinical dimensions of psychosis in university students presenting to primary care. Acta Psychiatr Scand 2011;123:21-7.
8. Janssen I, Krabbendam L, Bak M et al. Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr Scand 2004;109:38-45.
9. Read J, Van Os J, Morrison AP, Ross CA. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand 2005;112:330-50.
10. Varese F, Smeets F, Drukker M et al. Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull 2012;38:661-7.
11. Pelayo-Teran JM, Suarez-Pinilla P, Chadi N, Crespo-Facorro B. Gene-environment interactions underlying the effect of cannabis in first episode psychosis. Curr Pharm Des 2012;18:5024-35.
12. Harley M, Kelleher I, Clarke M et al. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychol Med 2010;40:1627-34.
13. Houston JE, Murphy J, Adamson G, Stringer M, Shevlin M. Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the National Comorbidity Survey. Schizophr Bull 2008;34:580-5.
14. Houston JE, Murphy J, Shevlin M, Adamson G. Cannabis use and psychosis: re-visiting the role of childhood trauma. Psychol Med 2011;18:1-10.
15. Konings M, Stefanis N, Kuepper R et al. Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk. Psychol Med 2012;42:149-59.
16. Gessa GL, Melis M, Muntoni AL, Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 1998;341:39-44.
17. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003;160:13-23.
18. Kuepper R, Henquet C, Lieb R, Wittchen HU, Van Os J. Non-replication of interaction between cannabis use and trauma in predicting psychosis. Schizophr Res 2011;131:262-3.
19. Collip D, Van Winkel R, Peerbooms O et al. COMT Val158Met-stress interaction in psychosis: role of background psychosis risk. CNS Neurosci Ther 2011;17:612-19.
20. Peerbooms O, Rutten BP, Collip D et al. Evidence that interactive effects of COMT and MTHFR moderate psychotic response to environmental stress. Acta Psychiatr Scand 2012;125:247-56.
21. Van Winkel R, Henquet C, Rosa A et al. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study. Am J Med Genet B Neuropsychiatr Genet 2008;147B:10-17.
22. Chen J, Lipska BK, Halim N et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004;75:807-21.
23. Meyer-Lindenberg A, Kohn PD, Kolachana B et al. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 2005;8:594-6.
24. Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999;51:593-628.
25. Caspi A, Moffitt TE, Cannon M et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005;57:1117-27.
26. Estrada G, Fatjo-Vilas M, Munoz MJ et al. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatr Scand 2011;123:485-92.
27. Henquet C, Rosa A, Delespaul P et al. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life. Acta Psychiatr Scand 2009;119:156-60.
28. Decoster J, Van Os J, Myin-Germeys I, De Hert M, Van Winkel R. Genetic variation underlying psychosis-inducing effects of cannabis: critical review and future directions. Curr Pharm Des 2012;18:5015-23.
29. Savitz J, Van Der Merwe L, Newman TK, Stein DJ, Ramesar R. Catechol-o-methyltransferase genotype and childhood trauma may interact to impact schizotypal personality traits. Behav Genet 2010;40:415-23.
30. Aguilera M, Arias B, Wichers M et al. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population. Psychol Med 2009;39:1425-32.
31. Arias B, Aguilera M, Moya J et al. The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety-related traits. Acta Psychiatr Scand 2012;125:194-202.
32. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured clinical interview of DSM-IV disorders-Research Version (SCID-RV). Washington, DC: American Psychiatric Association, 1997.
33. Maxwell M. Family interview for genetic studies (FIGS): manual for FIGS. Bethesda, MD: Clinical Neurogenetics Branch, Intramural Research Program, National Institutde of Mental Health, 1992.
34. Stefanis NC, Hanssen M, Smirnis NK et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 2002;32:347-58.
35. Konings M, Bak M, Hanssen M, Van Os J, Krabbendam L. Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatr Scand 2006;114:55-61.
36. Ros-Morente A, Vilagra-Ruiz R, Rodriguez-Hansen G, Wigman JH, Barrantes-Vidal N. Process of adaptation to Spanish of the Community Assessment of Psychic Experiences (CAPE). Actas Esp Psiquiatr 2011;39:95-105.
37. Bernstein DPFL. Childhood Trauma Questionnaire: a Retrospective Self-report. San Antonio: The Psychological Corporation, 1998.
38. Bernstein DP, Stein JA, Newcomb MD et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl 2003;27:169-90.
39. Raine A, Benishay D. The SPQ-B: a brief screening instrument for schyzotypal personality disorder. J Personal Disord 1995;9:346-55.
40. Spielberg CG, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
41. Gauderman W, Morrison J. QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies. http:/hydra.usc.edu/gxe 2006.
42. Nuevo R, Chatterji S, Verdes E, Naidoo N, Arango C, Ayuso-Mateos JL. The continuum of psychotic symptoms in the general population: a cross-national study. Schizophr Bull 2012;38:475-85.
43. Kokkevi A, Nic Gabhainn S, Spyropoulou M. Early initiation of cannabis use: a cross-national European perspective. J Adolesc Health 2006;39:712-19.
44. Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004;99:1333-41.
45. Compton MT, Furman AC, Kaslow NJ. Preliminary evidence of an association between childhood abuse and cannabis dependence among African American first-episode schizophrenia-spectrum disorder patients. Drug Alcohol Depend 2004;76:311-16.
46. Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM. Gene-environment interplay between cannabis and psychosis. Schizophr Bull 2008;34:1111-21.
47. Collip D, Myin-Germeys I, Van Os J. Does the concept of "sensitization" provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophr Bull 2008;34:220-5.
48. Zammit S, Owen MJ, Evans J, Heron J, Lewis G. Cannabis, COMT and psychotic experiences. Br J Psychiatry 2011;199:380-5.
49. Maclean KI, Littleton JM. Environmental stress as a factor in the response of rat brain catecholamine metabolism to delta8-tetrahydrocannabinol. Eur J Pharmacol 1977;41:171-82.
50. Di Forti M. Why do psychotic patients take cannabis? Psychol Med 2008;38:1071-2.
51. Zammit S, Wiles N, Lewis G. The study of gene-environment interactions in psychiatry: limited gains at a substantial cost? Psychol Med 2010;40:711-16.
52. Munafo MR, Flint J. Replication and heterogeneity in gene x environment interaction studies. Int J Neuropsychopharmacol 2009;12:727-9.
53. Duncan LE, Keller MC. A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. Am J Psychiatry 2011;168:1041-9.
54. Rutter M, Moffitt TE, Caspi A. Gene-environment interplay and psychopathology: multiple varieties but real effects. J Child Psychol Psychiatry 2006;47:226-61.
55. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985;41:361-72.
56. McClelland GH, Judd CM. Statistical difficulties of detecting interactions and moderator effects. Psychol Bull 1993;114:376-90.
57. Gerdner A, Allgulander C. Psychometric properties of the Swedish version of the Childhood Trauma Questionnaire-Short Form (CTQ-SF). Nord J Psychiatry 2009;63:160-70.
58. Thombs BD, Bernstein DP, Lobbestael J, Arntz A. A validation study of the Dutch Childhood Trauma Questionnaire-Short Form: factor structure, reliability, and known-groups validity. Child Abuse Negl 2009;33:518-23.
59. Di Forti M, Morgan C, Dazzan P et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry 2009;195:488-91.
60. Dragt S, Nieman DH, Schultze-Lutter F et al. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatr Scand 2012;125:45-53.